
Medical Induction for Mid trimester Abortion: A Hospital-based Descriptive Cross-sectional Study
Author(s) -
Jyotshna Sharma,
Sanjeeb Tiwari,
Manoj Pokhrel,
Lhakpa Dolma Lama
Publication year - 2020
Publication title -
journal of nepal medical association
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.176
H-Index - 19
eISSN - 1815-672X
pISSN - 0028-2715
DOI - 10.31729/jnma.5502
Subject(s) - medicine , misoprostol , pregnancy , medical abortion , mifepristone , obstetrics , abortion , gestation , cross sectional study , second trimester , complication , vacuum aspiration , gynecology , family planning , population , surgery , research methodology , genetics , environmental health , pathology , biology
Second trimester abortion is known as termination of pregnancy from 13- 28 weeks of gestation which can be further divided into early second trimester as 13-22 weeks and late as 23-28 weeks. In our study we have limited up to early second trimester. We intend to see the success rate of combination of mifepristone and misoprostol for medical induction, median time required for expulsion, complication and need of dilation and evacuation in some cases. This study also aims to give a review of current literature in mid trimester abortion with respect to efficacy, complication and also to provide evidencebase recommendation for safe regimens for mid trimester pregnancy termination.